Anticancer agent 318
Anticancer agent 318 (Compound 8 (6)) is a selective anticancer agent. Anticancer agent 318 can be metabolized by CYP1A1, CYP1A2 and CYP1B1. After bioactivation, Anticancer agent 318 exerts antiproliferative activity in breast cancer cells expressing CYP1. Anticancer agent 318 can be used in the research of breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2482789-24-0
- 화학식: C20H17NO4
- 분자량:335.35
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
CYP1A1 |
CYP1A2 |
CYP1B1 |
The anticancer agent 318 potently inhibits the proliferation of CYP1-expressing breast cancer cell lines MDA-MB-468 (IC50 = 0.08 μM) and TCDD-induced MCF-7 (IC50 = 0.006 μM), shows no toxicity toward non-tumorigenic MCF-10A cells (IC50 = 100 μM), and its activity depends on CYP1-mediated bioactivation[1].
The anticancer agent 318 (0-30 min) is metabolized by CYP1A1, CYP1A2 and CYP1B1 (but not CYP3A4) enzymes, producing four distinct metabolites via demethylenation, O-demethylation and hydroxylation reactions[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2482789-24-0
-
분자량 335.35
-
화학식 C20H17NO4
-
SMILES
COC1=CC(OC)=C(C=C1)C2=CC(C3=CC4=C(OCO4)C=C3)=CC=N2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)